Inhaltsseite: Home

ZKB Mini-Future Long auf Novo Nordisk -B-, Open End
Novo Nordisk A/S

ISIN: CH1305135530 Security: 130513553 Symbol: INO1TZ Life cycle
Secondary market

Bid Price 1.48

Ask Price 1.49

Currency CHF

Exchange SIX Structured Products

Volume 75'000.00

Volume 75'000.00

Date/time (delayed) 27.06.2024 05:15:00

Sell Buy 

Product Download

Security PDF for download Publication date
Termsheet 27.06.2024
Key Information Document DE 27.06.2024
Key Information Document EN 27.06.2024
Key Information Document FR 27.06.2024
Key Information Document IT 27.06.2024

Price data

  Bid Ask
Price 1.48 1.49
Volume 75'000.00 75'000.00
Date/time 27.06.24 17:15 27.06.24 17:15

Current data

Last price paid 1.49
Change -1.32% [ -0.02 ]
Last traded volume n.a. Unit
Cumulative volume n.a. Unit
Date/time 27.06.2024 17:20

Life cycle

Fixingn.a.
Settlement date05.02.2024
Last tradingn.a.
Final fixingn.a.
Currency redemptionCHF

Performance

Perf. since issue +230.00%
Year to date (YTD) n.a.
1 month +33.04%
3 months +53.61%
1 year n.a.
3 years n.a.

Key figures on issue

Issue price0.45
Underlying price on issue793.90
Premium0.01%
Premium p.a.n.a.
Leveragen.a.
Implied volatilityn.a.

Reference data

ISIN CH1305135530
Symbol INO1TZ
Security 130513553
Exchange SIX Structured Products
Currency CHF
Expiry n.a.
Underlying Novo Nordisk -B-, DK0062498333
Underlying ISIN DK0062498333
Funding level 722.324600
Stop-loss level 747.492400
Distance to stop-loss level 25.44%
Long/Short type Long
Subscription ratio 25.00
Issuer Zürcher Kantonalbank
Exercise type n.a.
Minimum execution n.a.
Value day 01.02.2024

Key figures

Premium 0.79%
Premium p.a. n.a.
Leverage 3.48
Moneyness in-the-money
Leverage n.a.
Delta n.a.
Intrinsic value 280.275400
Break-even n.a.
SSPA value at risk n.a.
SSPA risk rating n.a.

Product type

SSPA derivative category Leverage
SSPA code Mini future (2210)

Ajax loading